Abstract
In a number of experimental situations exogenously administered gangliosides have been demonstrated to speed recovery from axonotmesis. First demonstrated for the pre-and postganglionic sympathetic fibers of the cat nictitating membrane,1 it has now been demonstrated also for the rat sciatic nerve2 and rat tail nerve.3 The mechanism of action seems to be stimulation of the sprouting process.3,4 Hence, gangliosides would be expected to be beneficial in conditions such as traumatic nerve injury and mononeuritis from focal nerve infarction. Therapy would reduce the time of disability. Additionally, if regrowth of nerve is sometimes limited by fibrosis in the region of injury, then rapid growth out of this region would improve the quality of recovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
B. Ceccarelli, F. Aporti, and M. Finesso, Effects of brain gangliosides on functional recovery in experimental regeneration and reinnervation, in: “Advances in Experimental Medicine and Biology,” G. Porcellati, B. Ceccarelli, and G. Tettamanti, eds., Plenum Press, New York (1975).
A. Gorio, G. Carmignoto, L. Facci, and M. Finesso, Motor nerve sprouting induced by ganglioside treatment: possible implications for gangliosides on neuronal growth, Brain Res. 197:236 (1980).
F. Norido, R. Canella, and F. Aporti, Acceleration of nerve regeneration by gangliosides estimated by the somatosensory evoked potentials (SEP), Experientia 37:301 (1981).
A. Gorio, G. Carmignoto, and A. Ferrari, Axon sprouting stimulated by gangliosides: a new model for elongation and sprouting, in: “Gangliosides in Neurological and Neuromuscular Function, Development and Repair,” M. M. Rapport, A. Gorio, eds., Raven Press, New York (1981).
F. Norido, R. Canella, and A. Gorio, Ganglioside treatment of neuropathy in diabetic mice, Muscle and Nerve 5:107 (1982).
B. Mamoli, G. Brunner, R. Mader, and H. Schanda, Effects of cerebral gangliosides in the alcoholic polyneuropathies, Eur. Neurol. 19:320 (1980).
G. Pozza, V. Saibene, G. Comi, and N. Canal, The effect of ganglioside administration in human diabetic peripheral neuropathy, in: “Gangliosides in Neurological and Neuromuscular Function, Development and Repair,” M. M. Rapport, A. Gorio, eds., Raven Press, New York (1981).
S. Bassi, M. G. Albizzati, E. Calloni, and L. Brattola, Electromyographic study of diabetic and alcoholic Polyneuropathic patients treated with gangliosides, Muscle and Nerve 5:351 (1982).
H. Harrington, M. Hallett, and H. R. Tyler, Trial of ganglioside therapy for amyotrophic lateral sclerosis, Neurology 33(Suppl 2):101 (1983).
D. A. Greene, M. J. Brown, S. N. Braunstein, S. S. Schwartz, A. K. Asbury, and A. I. Winegrad, Comparison of clinical course and sequential electrophysiological tests in diabetics with symptomatic polyneuropathy and its implications for clinical trials, Diabetes 30:139 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Hallett, M., Harrington, H., Tyler, H.R., Flood, T., Slater, N. (1984). Trials of Ganglioside Therapy for Amyotrophic Lateral Sclerosis and Diabetic Neuropathy. In: Ledeen, R.W., Yu, R.K., Rapport, M.M., Suzuki, K. (eds) Ganglioside Structure, Function, and Biomedical Potential. Advances in Experimental Medicine and Biology, vol 174. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1200-0_48
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1200-0_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1202-4
Online ISBN: 978-1-4684-1200-0
eBook Packages: Springer Book Archive